AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Related articles in AJCN
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weinbrenner, T.
Right arrow Articles by Covas, M.-I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weinbrenner, T.
Right arrow Articles by Covas, M.-I.
Agricola
Right arrow Articles by Weinbrenner, T.
Right arrow Articles by Covas, M.-I.
American Journal of Clinical Nutrition, Vol. 83, No. 1, 30-35, January 2006
© 2006 American Society for Clinical Nutrition

ORIGINAL RESEARCH COMMUNICATION

Circulating oxidized LDL is associated with increased waist circumference independent of body mass index in men and women1,2,3,4,5

Tanja Weinbrenner, Helmut Schröder, Veronica Escurriol, Montserrat Fito, Roberto Elosua, Joan Vila, Jaume Marrugat and Maria-Isabel Covas

1 From the Department of Public Health, Universidad Miguel Hernández, Campus San Juan, Alicante, Spain (TW) and the Lipids and Cardiovascular Epidemiology Research Unit, Institut Municipal d'Investigació Mèdica (HS, VE, MF, RE, JV, JM, and M-IC), Barcelona, Spain

See corresponding editorial on page 1.

See corresponding CME exam on page 181.

2 TW and HS contributed equally to the study, and each can be regarded as first authors of this article.

3 Neither the entire paper nor any part of its content was published previously or is being submitted to another journal.

4 Supported by grant 2FD097-0297-CO2-01 from Fondo Europeo de Desarrollo Regional and partially supported by grant ALI-97-1607-CO2-01 and AGL-2000-0525-CO2-01 from Comisión Interministral de Ciencia y Tecnologia.

5 Address reprint requests to H Schröder, Institut Municipal d'Investigació Mèdica, Unitat de Lipids i Epidemiologia Cardiovascular, Carrer Doctor Aiguader, 80, 08003 Barcelona, Spain. E-mail: hschroeder{at}imim.es.


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Background: Obesity is associated with oxidative stress, and the oxidation of LDL is thought to play a crucial role in the generation of atherosclerotic lesions.

Objective: The objective was to describe the association of waist circumference (WC) and body mass index (BMI; in kg/m2) with plasma circulating oxidized LDL (ox-LDL) and C-reactive protein (CRP).

Design: This cross-sectional study included data for circulating ox-LDL and CRP from a subpopulation of 586 men and women enrolled in a population-based survey conducted in 2000 in Girona, Spain. Multivariate analysis was performed to describe the independent association of WC and BMI with ox-LDL and CRP.

Results: Multivariate logistic regression analysis adjusted for lifestyle, educational level, and dietary confounders showed a direct association of WC (quartile distribution) and BMI categories with ox-LDL (P for linear trend = 0.002) and CRP (P for linear trend = 0.004). Subjects in the top quartile of WC and with a BMI > 29.9 were at high risk of elevated circulating concentrations of ox-LDL and CRP. Further adjustment for cardiovascular disease risk factors did not substantially modify these associations. The risk of high ox-LDL concentrations in overweight (BMI = 25.0–29.9) or obese (BMI ≥ 30) subjects with a WC < 102 cm (men) or < 88 cm (women) was not significantly different from that in normal-weight subjects with these WCs. In contrast, overweight or obese subjects with higher WCs (WC ≥ 102 cm for men and ≥88 cm for women) were at significantly higher risk of increased ox-LDL.

Conclusion: High WC was associated with high concentrations of ox-LDL independently of BMI in the study population.

Key Words: Oxidized LDL • abdominal obesity • cardiovascular disease risk factors • weight • BMI


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Obesity, defined as a body mass index (BMI; in kg/m2) ≥30, is a chronic metabolic condition and the most prevalent metabolic disease in Western and westernized countries, with prevalence rates of 20% for males and 25% for females (1). Obesity is discussed as an independent risk factor for atherosclerosis because of its associations with oxidative stress (2) and inflammation (3). In particular, the accumulation of abdominal fat, which can be indirectly measured through waist circumference (WC), is an important coronary artery disease (CAD) risk factor. This is due to its association with a series of metabolic disorders such as diabetes mellitus, hypertension, and dyslipidemia (4).

Oxidation of LDL is a hallmark of atherosclerosis development (5). Patients with manifest CAD have elevated plasma concentration of circulating oxidized LDL (ox-LDL) (6-8), which are associated with the severity of symptoms (6, 9) and degree of CAD (7). Circulating ox-LDL has been shown to be a prognostic marker of CAD in cardiac transplant patients (10). The few studies that used circulating ox-LDL to investigate oxidative stress induced by obesity have shown decreased circulating ox-LDL concentrations in morbidly obese patients after weight loss following surgery (11). They have also shown decreased concentrations in postmenopausal women after a 12-wk diet-induced weight loss (12). However, the results concerning the correlations between BMI and ox-LDL are controversial (11, 12). Concentrations of circulating ox-LDL and ox-LDL antibodies did not vary significantly between overweight and normal-weight subjects in a Japanese population. In this population, however, significantly higher odds ratio for high serum ox-LDL were observed in both obese females and in obese subjects with hypertension (13).

Higher serum concentrations of CRP have been found in obese patients (BMI > 30) (14) and have been shown to decrease with weight loss (15). CRP concentrations have been shown to be directly related with malondialdehyde (MDA)-modified LDL concentrations (16).

It has been shown that obesity increases oxidative stress (17). Adipose tissue is a highly metabolic active organ. Hence, it might be reasonable to assume that abdominal fat is closely involved in the production of oxidative stress. However, data on the association of abdominal fat and oxidative stress are scarce.

The hypothesis of the present study was that abdominal fat, measured indirectly through WC, is independently related to circulating ox-LDL and inflammatory markers. For this purpose, we analyzed plasma concentrations of circulating ox-LDL and CRP in a random subsample from a cross-sectional survey. In addition, we determined the independent association of circulating ox-LDL and CRP with WC and BMI.


   SUBJECTS AND METHODS
TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
RESULTS
 DISCUSSION
 REFERENCES
 
Subjects
Six thousand free-living Spanish men and women aged 25–74 y were randomly selected from the general population of Girona according to the 1996 census and participated in this study from 1999 to 2000. After census errors were excluded, 4539 eligible subjects were left, of whom 3179 agreed to participate. In vivo ox-LDL was measured in a subpopulation of 308 men and 279 women (total of 587 ox-LDL samples). The study was conducted according to the guidelines of the Helsinki Declaration, and the study protocol was approved by an ethics committee. All participants gave their informed consent.

Laboratory measurements
Venous blood was obtained in the morning after the subjects had fasted for ≥12 h and was kept frozen at –40 °C until assayed. The concentration of ox-LDL in plasma was measured with a sandwich enzyme-linked immunosorbent assay procedure by using the murine monoclonal antibody mAb-4E6 as capture antibody (bound to microtitration wells) and a peroxidase-conjugated antiapolipoprotein B antibody recognizing ox-LDL bound to the solid phase (Mercodia AB, Uppsala, Sweden). Non-high sensitive quantitative determination of C-reactive protein (CRP) was performed with an immunoturbidimetric assay (Roche Diagnostics, Mannheim, Germany) on a Cobas Mira analyzer. The sensitivity of the CRP method used was lower than that of high-sensitivity (hs)-CRP; therefore, the top quartile of the CRP distribution level was used as a cutoff for high CRP values. Serum glucose, total cholesterol (TC), HDL cholesterol, and triacylglycerol concentrations were determined by using enzymatic kits (Roche Diagnostic, Basel, Switzerland) adapted to a Cobas Mira Plus autoanalyzer (Hoffmann-La Roche, Basel, Switzerland). LDL cholesterol was calculated with the Friedewald formula.

Other measurements
A precision scale of easy calibration was used to measure weight while the subjects were in their underwear. The readings were rounded to 200 g. Height was measured in the standing position, and the measurements were rounded to 5 mm. BMI was determined as weight (kg) divided by height squared (m2). WC was measured at the level midway between the lowest rib margin and the iliac crest. Measurements were taken with a tape measure in centimeters and rounded to 0.5 cm while the subject was standing. Abdominal obesity was defined as a WC ≥ 88 cm in women and ≥102 cm in men (18). Blood pressure was measured with a standard mercury sphygmomanometer.

Food consumption and nutrient intakes were measured with the use of a validated food-frequency questionnaire (19), which was administered by a trained interviewer. Energy consumption and nutrient intakes were calculated from the food-frequency questionnaire by using MEDISYSTEM 2000 software (Conaycite, Madrid, Spain). Leisure-time physical activity was measured with the Minnesota physical leisure-time questionnaire, which had been previously validated for Spanish men and women (20, 21). Information on smoking and alcohol drinking habits was obtained with the use of a structured open-ended questionnaire. Participants were categorized as never smokers, former smokers, and current smokers. The latter group was asked to report the average daily amount of cigarettes smoked. The participants were asked to report their typical consumption of alcohol beverages during the past week, and the average alcohol intake was calculated. The participants were categorized as non-alcohol consumers, moderate alcohol consumers (≤20 g/d), and elevated alcohol consumers (>20 g/d). The educational status was categorized as basic education, secondary school, and university.

Statistical analyses
General linear modeling procedures (PROC GLM, version 8.0; SAS Institute Inc, Cary, NC) were used to estimate age, lifestyle, and cardiovascular disease risk factors according to weight categories and WC. Weight categories were defined as normal weight (BMI = 18.5–24.9), overweight (BMI = 25.0–29.9), and obesity (BMI ≥ 30). Quartiles of WC were calculated separately for men and women. The prevalence of abdominal obesity (WC ≥ 102 cm in men and 88 cm in women) corresponds to 0%, 0%, 11%, and 100% for the first, second, third, and top quartiles, respectively.

The associations of ox-LDL and CRP with the weight categories and quartiles of WC were estimated by logistic regression analysis with the use of the PROCLOGISTIC procedure of SAS (version 8.0; SAS Institute Inc). CRP showed a nonparametric distribution that was not corrected by logarithmic transformation. Hence, linear regression analysis including this variable was not feasible. Furthermore, BMI and WC showed a high colinearity (Pearson's correlation coefficient: r = 0.72) in the present study population. For these reasons we decided to use logistical regression models instead of linear regression models.

The weight categories (normal weight, overweight, and obesity) and quartiles of WC were introduced as predictor variables for circulating ox-LDL (top tertile of plasma concentration of ox-LDL) and CRP (top quartile of plasma concentrations of CRP). The first model was controlled for age (y, continuous variable), leisure-time physical activity [metabolic equivalents (METs; continuous variable)], smoking and alcohol consumption (none; moderate: ≤20 g/d; and elevated >20 g/d), educational level (basic education, secondary school, university; categorical variable), energy consumption (kcal; continuous variable), vitamin C (mg; continuous variable), vitamin E (mg; continuous variable), and polyunsaturated fatty acids (g; continuous variable). The second model was additionally adjusted for diabetes (binary; categorical variable), high concentrations of LDL cholesterol (binary; categorical variable), and low HDL-cholesterol concentrations (binary; categorical variable).

Serious colinearity problems were observed when both variables (BMI and WC) were included in the model. When we tested the linear regression model for colinearity we found that the variance inflation factor was not so large (2.302; clearly lower than the classic value of 10) and, consequently, tolerance [(1/2.302) = 0.434] was considered acceptable. However, the 2 eigenvalues near zero (0.015 and 0.006) indicate 2 colinearities among predictors. Consequently, the condition indexes were very high (14.17 and 21.98), which suggested at least moderate colinearity. Additionally, the proportion of total variance of the predictors were high (BMI = 0.92; circumference = 0.82) and were also associated with the smallest eigenvalue. These data show that serious colinearity problems exist. Hence, it is reasonable to assume that a statistical analysis that includes both variables would lead to misleading results. Therefore, we created a new variable that we included in both logistical and linear regression models (as a dummy variable). This was carried out to explore in detail whether an independent association of WC with ox-LDL (linear and logistic regression analysis) and CRP (logistic regression analysis only) existed. For this purpose, the subjects were characterized through BMI and WC categories and grouped as follows: 1) BMI = 18.5–24.9 and WC < 102 cm in men and <88 cm in women; 2) BMI = 25.0–29.9 and WC < 102 cm in men and <88 cm in women; 3) BMI = 25.0–29.9 and WC ≥ 102 cm in men and ≥88 cm in women; 4) BMI ≥ 30 and WC < 102 cm in men and <88 cm in women; and 5) BMI ≥ 30 and WC ≥ 102 cm in men and ≥88 cm in women. Tests for the interaction of BMI categories and quartiles of WC with age and sex were performed. No significant interaction was found. Dietary supplement consumption was low in the present study population (all supplements: 5%; vitamin supplements: 1.3%) and, hence, was not included as a covariable in the linear or logistical regression analysis. Differences were considered significant if P < 0.05.


   RESULTS
TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
DISCUSSION
 REFERENCES
 
General characteristics of the study population according to weight classification and quartiles of WC are presented in Table 1Go. Age and plasma concentrations of ox-LDL increased across weight categories and quartiles of WC. In contrast, BMI and WC were inversely associated with energy consumption and dietary intake of polyunsaturated fat (Table 1Go). The prevalence of subjects with diabetes, hypertension, low concentrations of HDL cholesterol, and high concentrations of LDL cholesterol increased across weight categories and quartiles of WC. Subjects with higher BMIs and WCs smoked less and had a lower educational level than did those with a lower WC.


View this table:
[in this window]
[in a new window]
  		TABLE 1 Characteristics of the study participants1

 
Data on the association of weight categories and quartiles of WC with circulating ox-LDL are shown in Table 2Go. BMI and WC were directly associated with high concentrations of circulating ox-LDL after control for sex, age, total energy consumption, leisure-time physical activity, smoking and alcohol drinking status, and dietary intakes of vitamin C, vitamin E, ß-carotene, and polyunsaturated fatty acids (Table 2Go, model 1). The strength of these associations was not substantially affected after additional adjustment for other cardiovascular disease risk factors (Table 2Go, model 2).


View this table:
[in this window]
[in a new window]
  		TABLE 2 Relative risk (odds ratio; OR) and 95% CIs of having high oxidized LDL (ox-LDL) concentrations, according to categories of BMI and quartiles of waist circumference1

 
The associations of elevated concentrations of CRP with weight categories and quartiles of WC are shown in Table 3Go. High concentrations of CRP were directly associated with WC and BMI (Table 3Go, model 1). The association of CRP with BMI, but not with WC, was attenuated after further control for cardiovascular disease risk factors (Table 3Go, model 2).


View this table:
[in this window]
[in a new window]
  		TABLE 3 Relative risk (odds ratio; OR) and 95% CIs of having high C-reactive protein concentrations, according to categories of BMI and quartiles of waist circumference1

 
Multiple logistic and linear regression analyses showed that a high WC (>102 cm in men and >88 cm in women) in overweight (BMI = 25.0–29.9) and obese (BMI ≥ 30) subjects was directly associated with ox-LDL (Tables 4Go and 5Go) and CRP (Table 4Go) compared with subjects with normal weight (BMI = 18.5–24.9) and a normal WC (<102 cm in men and <88 cm in women).


View this table:
[in this window]
[in a new window]
  		TABLE 4 Relative risk (odds ratio; OR) and 95% CIs of having high oxidized LDL (ox-LDL) and C-reactive protein (CRP) concentrations, according to combined weight and waist circumference (WC) classifications1

 

View this table:
[in this window]
[in a new window]
  		TABLE 5 Multiple linear regression analysis of the association of circulating oxidized LDL (ox-LDL) concentrations with waist circumference (WC) and BMI1

 

   DISCUSSION
TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
REFERENCES
 
The main finding of the present study was that high plasma concentrations of circulating ox-LDL and CRP were directly associated with WC (quartile distribution) and BMI categories. Most importantly, an increased amount of abdominal fat (defined by WC) was associated, independently of BMI and other confounder variables, with these biomarkers of oxidative stress and inflammation, which are known risk factors of atherosclerosis development.

A direct relation was previously found between general obesity and markers of oxidative stress and the susceptibility of lipids to oxidative modification in humans independently of other coronary heart disease risk factors (15, 22-26). Furthermore, Holvoet et al (27) showed that BMI is one of the strongest predictors of circulating ox-LDL concentrations. In addition, studies that have investigated the reduction of total body fat have shown reductions in plasma markers of oxidative stress after weight loss induced by diet (12, 15, 23, 28, 29), surgery (11), and pharmacologic agents (30). Reactive oxygen species generation by isolated leukocytes was also reduced after a 4-wk diet-induced weight loss (23). Furthermore, 2 population-based studies have shown significant correlations of urinary isoprostanes (2) and ox-LDL/LDL ratio (31) with BMI. These findings indicated that weight is an important determinant for oxidative stress.

The emphasis on abdominal fat has been suggested because of the strong adverse health effects associated with excessive abdominal fat. An important finding of the present study was that the risk of having high ox-LDL concentrations was independently related to increased WCs—an indirect measure of abdominal fat. Davi et al (15) showed a relation between the degree of abdominal fat and enhanced lipid peroxidation, analyzed by urinary isoprostanes, in women. In contrast, Myara et al (24) showed no correlation between lag time for LDL oxidation and waist-to-hip ratio in nondiabetic, normotensive women. However, lag time is an in vitro test and, hence, data from lag time determinations should be carefully interpreted when compared with in vivo analysis such as plasma concentrations of circulating ox-LDL. The association of WC with ox-LDL was strong and consistent in the present study. Even after adjustment for lifestyle, cardiovascular disease risk factors, and BMI, we found a 256% higher risk in subjects in the top quartile of WC.

The mechanisms by which abdominal adiposity per se could induce increased oxidative stress are not well defined. One hypothesis that has been suggested is that oxidative stress could be induced by low-grade systemic inflammation (16), mainly characterized by higher concentrations of serum CRP and plasma interleukin 6 (32). Several authors have suggested that a low degree of inflammation in obese persons is caused by a high secretion of proinflammatory cytokines, such as tumor necrosis factor {alpha} (33, 34). This in turn induces the production of interleukin 6. Interleukin 6 is a prime regulator of CRP synthesis in the liver (35), which leads to a low-grade inflammatory state that induces the production of free radicals and leads to increased lipid peroxidation (14, 15). In the present study, we showed that elevated CRP concentrations were related to increased abdominal fat, indirectly measured by WC. This finding is in line with the findings of previous studies, ie, higher CRP concentrations with increasing levels of abdominal fat (3, 14, 16). In the mixed model we found a tendency for a high risk of high CRP concentrations in obese subjects with normal WCs. However, this association was not statistically significant, which may have been due in part to the low number of subjects in this group. Hence, these data suggest that the association of CRP with WC was not independent of BMI. We could not show a change in the direction and magnitude of the association between WC and ox-LDL after CRP was controlled for. This result might indicate that ox-LDL concentrations increase independently of CRP in subjects with high WCs. Further studies, however, are needed to examine the relation between several markers of oxidative stress and inflammation.

Another trigger of increased oxidative stress and increased inflammation, other than cytokines, is leptin—a plasma protein secreted by adipocytes. Plasma leptin concentrations are elevated in obese humans and correlate positively with body fat mass in lean and obese subjects (36). It has been shown that leptin might exert an atherogenic effect through the generation of oxidative stress in endothelial cells (37) and the induction of the production of interleukin 6, CRP, and other acute phase reactants. This would contribute to the maintenance of a chronic low-grade inflammation state (38). Porreca et al (12) showed significant correlations between circulating ox-LDL and leptin in postmenopausal women without coronary heart disease risk factors. The authors suggested that leptin had a stronger effect on oxidative modification of LDL than of CRP. This was because the association of ox-LDL with CRP disappeared in a multivariate model, and the change in ox-LDL concentrations, from weight loss, was predicted only by changes in leptin.

Other factors that have been discussed in relation to increased oxidative stress in obesity are insulin resistance (2) and lipoprotein abnormalities (39). Insulin resistance has been shown to be induced by tumor necrosis factor {alpha} (40) and has shown direct associations with lipid peroxidation (41-43). Ho et al (44) found only weak associations between insulin resistance and circulating ox-LDL. In conclusion, a high WC is associated with high concentrations of circulating ox-LDL and CRP, independently of BMI.


   ACKNOWLEDGMENTS
 
We appreciate the English revision made by Stephanie Lonsdale.

TW and HS led the data analysis and writing of the manuscript. VE, MF, RE, JV, JM, and M-IC participated in the discussion and interpretation of results and in the writing of the manuscript. HS, VE, MF, RE, JV, JM, and M-IC provided their expertise in the data analysis and interpretation and discussion of the results and made substantial suggestions on the manuscript. All authors stated having no conflict of interest related to the authorship of the submitted paper.


   REFERENCES
TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. James PT. Obesity: the worldwide epidemic. Clin Dermatol 2004; 22: 276–80.[Medline]
  2. Keaney JF Jr, Larson MG, Vasan RS, et al. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol 2003; 23: 434–9.[Abstract/Free Full Text]
  3. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999; 282: 2131–5.[Abstract/Free Full Text]
  4. Sowers JR. Obesity as a cardiovascular risk factor. Am J Med 2003; 115(suppl): 37S–41S.
  5. Witztum JL. The oxidation hypothesis of atherosclerosis. Lancet 1994; 344: 793–5.[Medline]
  6. Holvoet P, Vanhaecke J, Janssens S, Van de WF, Collen D. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation 1998; 98: 1487–94.[Medline]
  7. Holvoet P, Stassen JM, Van Cleemput J, Collen D, Vanhaecke J. Oxidized low density lipoproteins in patients with transplant-associated coronary artery disease. Arterioscler Thromb Vasc Biol 1998; 18: 100–7.[Abstract/Free Full Text]
  8. Toshima S, Hasegawa A, Kurabayashi M, et al. Circulating oxidized low density lipoprotein levels. A biochemical risk marker for coronary heart disease. Arterioscler Thromb Vasc Biol 2000; 20: 2243–7.[Abstract/Free Full Text]
  9. Ehara S, Ueda M, Naruko T, et al. Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation 2001; 103: 1955–60.[Medline]
  10. Holvoet P, Van Cleemput J, Collen D, Vanhaecke J. Oxidized low density lipoprotein is a prognostic marker of transplant-associated coronary artery disease. Arterioscler Thromb Vasc Biol 2000; 20: 698–702.[Abstract/Free Full Text]
  11. Uzun H, Zengin K, Taskin M, Aydin S, Simsek G, Dariyerli N. Changes in leptin, plasminogen activator factor and oxidative stress in morbidly obese patients following open and laparoscopic Swedish adjustable gastric banding. Obes Surg 2004; 14: 659–65.[Medline]
  12. Porreca E, Di Febbo C, Moretta V, et al. Circulating leptin is associated with oxidized LDL in postmenopausal women. Atherosclerosis 2004; 175: 139–43.[Medline]
  13. Suzuki K, Ito Y, Ochiai J, et al. Relationship between obesity and serum markers of oxidative stress and inflammation in Japanese. Asian Pac J Cancer Prev 2003; 4: 259–66.[Medline]
  14. Barinas-Mitchell E, Cushman M, Meilahn EN, Tracy RP, Kuller LH. Serum levels of C-reactive protein are associated with obesity, weight gain, and hormone replacement therapy in healthy postmenopausal women. Am J Epidemiol 2001; 153: 1094–101.[Abstract/Free Full Text]
  15. Davi G, Guagnano MT, Ciabattoni G, et al. Platelet activation in obese women: role of inflammation and oxidant stress. JAMA 2002; 288: 2008–14.[Abstract/Free Full Text]
  16. Hulthe J, Wikstrand J, Fagerberg B. Relationship between C-reactive protein and intima-media thickness in the carotid and femoral arteries and to antibodies against oxidized low-density lipoprotein in healthy men: the Atherosclerosis and Insulin Resistance (AIR) study. Clin Sci (Lond) 2001; 100: 371–8.[Medline]
  17. Urakawa H, Katsuki A, Sumida Y, et al. Oxidative stress is associated with adiposity and insulin resistance in men. J Clin Endocrinol Metab 2003; 88: 4673–6.[Abstract/Free Full Text]
  18. Lean ME, Han TS, Morrison CE. Waist circumference as a measure for indicating need for weight management. BMJ 1995; 311: 158–61.[Abstract/Free Full Text]
  19. Schroder H, Covas MI, Marrugat J, et al. Use of a three-day estimated food record, a 72-hour recall and a food-frequency questionnaire for dietary assessment in a Mediterranean Spanish population. Clin Nutr 2001; 20: 429–37.[Medline]
  20. Elosua R, Marrugat J, Molina L, Pons S, Pujol E. Validation of the Minnesota Leisure Time Physical Activity Questionnaire in Spanish men. The MARATHOM Investigators. Am J Epidemiol 1994; 139: 1197–209.[Abstract/Free Full Text]
  21. Elosua R, Garcia M, Aguilar A, Molina L, Covas MI, Marrugat J. Validation of the Minnesota Leisure Time Physical Activity Questionnaire In Spanish Women. Investigators of the MARATDON Group. Med Sci Sports Exerc 2000; 32: 1431–7.[Medline]
  22. Mutlu-Turkoglu U, Oztezcan S, Telci A, et al. An increase in lipoprotein oxidation and endogenous lipid peroxides in serum of obese women. Clin Exp Med 2003; 2: 171–4.[Medline]
  23. Dandona P, Mohanty P, Ghanim H, et al. The suppressive effect of dietary restriction and weight loss in the obese on the generation of reactive oxygen species by leukocytes, lipid peroxidation, and protein carbonylation. J Clin Endocrinol Metab 2001; 86: 355–62.[Abstract/Free Full Text]
  24. Myara I, Alamowitch C, Michel O, et al. Lipoprotein oxidation and plasma vitamin E in nondiabetic normotensive obese patients. Obes Res 2003; 11: 112–20.[Medline]
  25. Van Gaal LF, Vertommen J, De Leeuw IH. The in vitro oxidizability of lipoprotein particles in obese and non-obese subjects. Atherosclerosis 1998; 137(suppl): S39–44.
  26. Olusi SO. Obesity is an independent risk factor for plasma lipid peroxidation and depletion of erythrocyte cytoprotectic enzymes in humans. Int J Obes Relat Metab Disord 2002; 26: 1159–64.[Medline]
  27. Holvoet P, Mertens A, Verhamme P, et al. Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease. Arterioscler Thromb Vasc Biol 2001; 21: 844–8.[Abstract/Free Full Text]
  28. Vasankari T, Fogelholm M, Kukkonen-Harjula K, et al. Reduced oxidized low-density lipoprotein after weight reduction in obese premenopausal women. Int J Obes Relat Metab Disord 2001; 25: 205–11.[Medline]
  29. Raitakari M, Ilvonen T, Ahotupa M, et al. Weight reduction with very-low-caloric diet and endothelial function in overweight adults: role of plasma glucose. Arterioscler Thromb Vasc Biol 2004; 24: 124–8.[Abstract/Free Full Text]
  30. Yesilbursa D, Serdar Z, Serdar A, Sarac M, Coskun S, Jale C. Lipid peroxides in obese patients and effects of weight loss with orlistat on lipid peroxides levels. Int J Obes Relat Metab Disord 2005; 29: 142–5.[Medline]
  31. Brouwers A, Langlois M, Delanghe J, et al. Oxidized low-density lipoprotein, iron stores, and haptoglobin polymorphism. Atherosclerosis 2004; 176: 189–95.[Medline]
  32. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 2000; 148: 209–14.[Medline]
  33. Mohamed-Ali V, Goodrick S, Rawesh A, et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 1997; 82: 4196–200.[Abstract/Free Full Text]
  34. Mohamed-Ali V, Goodrick S, Bulmer K, Holly JM, Yudkin JS, Coppack SW. Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo. Am J Physiol 1999; 277: E971–5.
  35. Coppack SW. Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc 2001; 60: 349–56.[Medline]
  36. Mantzoros CS. The role of leptin in human obesity and disease: a review of current evidence. Ann Intern Med 1999; 130: 671–80.[Abstract/Free Full Text]
  37. Beltowski J, Wojcicka G, Jamroz A. Leptin decreases plasma paraoxonase 1 (PON1) activity and induces oxidative stress: the possible novel mechanism for proatherogenic effect of chronic hyperleptinemia. Atherosclerosis 2003; 170: 21–9.[Medline]
  38. Bullo M, Garcia-Lorda P, Megias I, Salas-Salvado J. Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression. Obes Res 2003; 11: 525–31.[Medline]
  39. James RW, Brulhart-Meynet MC, Lehmann T, Golay A. Lipoprotein distribution and composition in obesity: their association with central adiposity. Int J Obes Relat Metab Disord 1997; 21: 1115–20.[Medline]
  40. Hansen LL, Ikeda Y, Olsen GS, Busch AK, Mosthaf L. Insulin signaling is inhibited by micromolar concentrations of H2O2. Evidence for a role of H2O2 in tumor necrosis factor alpha-mediated insulin resistance. J Biol Chem 1999; 274: 25078–84.[Abstract/Free Full Text]
  41. Krieger-Brauer HI, Kather H. Human fat cells possess a plasma membrane-bound H2O2-generating system that is activated by insulin via a mechanism bypassing the receptor kinase. J Clin Invest 1992; 89: 1006–13.[Medline]
  42. Quinones-Galvan A, Sironi AM, Baldi S, et al. Evidence that acute insulin administration enhances LDL cholesterol susceptibility to oxidation in healthy humans. Arterioscler Thromb Vasc Biol 1999; 19: 2928–32.[Abstract/Free Full Text]
  43. Carantoni M, Abbasi F, Warmerdam F, et al. Relationship between insulin resistance and partially oxidized LDL particles in healthy, nondiabetic volunteers. Arterioscler Thromb Vasc Biol 1998; 18: 762–7.[Abstract/Free Full Text]
  44. Ho RC, Davy K, Davy B, Melby CL. Whole-body insulin sensitivity, low-density lipoprotein (LDL) particle size, and oxidized LDL in overweight, nondiabetic men. Metabolism 2002; 51: 1478–83.[Medline]
Received for publication June 3, 2005. Accepted for publication August 1, 2005.


Related articles in AJCN:

Oxidized LDL and abdominal obesity: a key to understanding the metabolic syndrome
Robert H Knopp and Pathmaja Paramsothy
AJCN 2006 83: 1-2. [Full Text]  

Continuing Medical Education

AJCN 2006 83: 181-182. [Full Text]  



This article has been cited by other articles:


Home page
 Eur Heart JHome page
M. Grau, M. Guxens, I. Subirana, M. Fito, M.-I. Covas, B. Jacquemin, J. Sunyer, T. Lanki, S. Picciotto, T. Bellander, et al.
South-to-North gradient in lipid peroxidation in men with stable coronary artery disease in Europe
Eur. Heart J., December 1, 2007; 28(23): 2841 - 2849.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
J. M. Catov, L. M. Bodnar, R. B. Ness, S. J. Barron, and J. M. Roberts
Inflammation and Dyslipidemia Related to Risk of Spontaneous Preterm Birth
Am. J. Epidemiol., December 1, 2007; 166(11): 1312 - 1319.
[Abstract] [Full Text] [PDF]

Home page
 Epidemiol RevHome page
S. Musaad and E. N. Haynes
Biomarkers of Obesity and Subsequent Cardiovascular Events
Epidemiol. Rev., May 10, 2007; (2007) mxm005v1.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Mohn, V. Chiavaroli, M. Cerruto, A. Blasetti, C. Giannini, T. Bucciarelli, and F. Chiarelli
Increased Oxidative Stress in Prepubertal Children Born Small for Gestational Age
J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1372 - 1378.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
P. Holvoet
Obesity, the metabolic syndrome, and oxidized LDL
Am. J. Clinical Nutrition, June 1, 2006; 83(6): 1438 - 1438.
[Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
H. Schroder and M.-I. Covas
Reply to P Holvoet
Am. J. Clinical Nutrition, June 1, 2006; 83(6): 1438 - 1439.
[Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Related articles in AJCN
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weinbrenner, T.
Right arrow Articles by Covas, M.-I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weinbrenner, T.
Right arrow Articles by Covas, M.-I.
Agricola
Right arrow Articles by Weinbrenner, T.
Right arrow Articles by Covas, M.-I.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS